|
|
||||||||
Division of Nuclear Medicine, Department of Radiology, and Division of Infectious Diseases, Massachusetts General Hospital
Departments of Radiology and Medicine, Harvard Medical School, Boston, Massachusetts
Correspondence: For reprints contact: Alan J. Fischman, MD, PhD, Division of Nuclear Medicine, Massachusetts General Hospital, Fruit Street, Boston, 02114.
ABSTRACT
Intact IgG, Fc, Fab, and 1/2Fc (reduced and alkylated Fc) were coupled to DTPA, labeled with indium-111 and administered to rats to compare the ability of fragments of IgG to localize at focal sites of inflammation. Two sets of experiments were performed: First, 1, 6, 24, and 48 hr after injection, biodistribution was determined in healthy animals; second, localization at sites of inflammation was determined by scintillation camera imaging of animals with deep-thigh infection due to Escherichia coil. The biodistribution studies demonstrated differences in kidney and liver localization: IgG < Fc < Fab < 1/2Fc (kidney), Fc < 1/2Fc < IgG < Fab (liver). The imaging studies revealed that target-to-background ratio (T/B) and percent residual activity (%RA) for IgG was significantly greater (p < 0.01) than 1/2 Fc or Fab, and T/B for IgG was greater (p < 0.01) than Fc. These studies suggest that the Fc portion of IgG is the fragment with the best imaging properties.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |